Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Perceptions have shifted dramatically in the past few years on the therapeutic value of illicit drugs such as ecstasy. But questions still linger about what FDA approval might look like.
A raft of commercial lunar missions are taking off in 2023. The first lander is set to touch down this month, signalling a new era for Moon science and exploration.
Science is beginning to uncover the multiple processes driving persistent pain. But connecting people with treatments that will help them remains a challenge.
The approval of an antibody therapy that pauses the progression of type 1 diabetes is a first in the field, and some say a model for other drug developers.
South Asian weather is becoming increasingly difficult to forecast as monsoons grow more erratic — and global warming is raising the risks posed by violent rain storms.